Jacobs was awarded an engineering, procurement and construction management contract with Spark Therapeutics, Inc. (Spark) to build its Gene Therapy Innovation Center in the University City area of West Philadelphia. When complete, the multi-story facility will serve as a global center of excellence for gene therapy manufacturing and advance the science of gene therapy.
According to Spark, the first phase of the project includes an initial investment of $575 million, and the anticipated 500,000 square foot facility nearly doubles the company’s physical footprint in Philadelphia. The facility is estimated to be completed in 2026.
“Our goal is to build an innovative facility that supports Spark’s mission to drive science forward,” says Jacobs Advanced Facilities Senior Vice President Koti Vadlamudi. “It will also be the first gene therapy manufacturing facility of its size in Philadelphia. We stand ready to support Spark’s vision of a world where no life is limited by genetic disease.”
Jacobs has provided solutions for more than 30 clients in the cell and gene therapy market on projects involving full-scale launch and production facilities with multiple modalities.
You might be interested in...
Q&A: Talking with Subject Matter Expert and Lead Process Engineer, Life Sciences, Julie Vickers
Working at the forefront of life sciences, Subject Matter Expert (SME) and Lead Process Engineer Julie Vickers deploys creative thinking and high-level problem solving to turn design concepts into next-generation cell and gene therapy and mRNA facilities. We interviewed Julie about trends in facility design, how mRNA has the potential to transform product delivery and the importance of diverse, inclusive teams to drive innovation.
Health & Life Sciences
Jacobs’ deep subject matter expertise across diverse scientific, infrastructure, environmental and digital domains in biopharmaceutical manufacturing, health governance, health infrastructure, and operations advisory provides market differentiation and distinct competitive advantage.
Advancing the Facilities of the Life Sciences Industry
Advances in medicine over the past 30 years have extended and improved the quality of life for people around the world. In this episode of Inflection Points, John Noble, Jacobs Vice President and General Manager, Life Sciences talks about the life sciences industry and how integrated project management helps firms get their facilities done on time.